🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction
NCT07306182Acute Anterior ST-Segment Elevation Myocardial Infarction
Beijing Sungen Biomedical Technology Co., Ltd
Phase 2
210
Shanghai
2026-03-09
Recruiting
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT07218341Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic
Eli Lilly and Company
Phase 4
150
Beijing, Changsha, Guangdong, Guangzhou, Lanzhou, Nanchang, Shanghai, Taizhou
2026-03-09
Recruiting
A Clinical Study of AFN50 in the Treatment of Autoimmune Diseases
NCT07448298Relapsed/Refractory Autoimmune Diseases
Beijing Boren Hospital
Phase EARLY_PHASE1
18
Beijing
2026-03-09
Not yet open
Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets
NCT07486453Primary Hypertension
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 1
60
Hefei
2026-03-09
Recruiting
Effect of Negative Pressure Suction on Fluid Absorption and Infection in Flexible Ureteroscopy
NCT07492147Kidney Stones
Lanzhou University Second Hospital
Observational
400
Lanzhou
2026-03-09
Recruiting
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
NCT07431177Non-segmental Vitiligo
Novartis Pharmaceuticals
Phase 2
210
Guangzhou, Wuhan, Beijing, Shanghai
2026-03-09
Recruiting
A Study of SHR-2173 in Participants With Primary IgA Nephropathy
NCT07354932Primary IgA Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 2
84
Guangzhou, Shanghai
2026-03-09
Recruiting
This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis
NCT07303790Multiple Sclerosis
Daishi Tian
Phase EARLY_PHASE1
9
Hubei
2026-03-09
Not yet open
A Study to Evaluate the Biosimilarity of GLR1044 Injection and Dupilumab Injection (Dupixent®) in Healthy Adult Male Subjects
NCT07334496Biosimilarity
Gan & Lee Pharmaceuticals.
Phase 1
198
Beijing
2026-03-09
Recruiting
Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria.
NCT07402213Chronic Spontaneous Urticaria
Jemincare
Phase 3
240
Beijing
2026-03-09
Recruiting
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
NCT07491445Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc.
Phase 3
900
2026-03-09
Recruiting
Baricitinib for Post-HSCT Persistent Thrombocytopenia
NCT07535645Persistent Thrombocytopenia, Allogeneic Hematopoietic Stem Cell Transplantation
Peking University People's Hospital
Phase 1/2
28
Beijing
2026-03-09
Not yet open
A Study to Evaluate the Efficacy and Safty of 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)
NCT07349329Axial Spondyloarthritis, Non-Radiographic
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 3
380
Beijing
2026-03-09
Recruiting
Acupressure for Cough in Lung Cancer Survivors
NCT07315672Lung Cancer (Diagnosis), Acupressure, Coughing, Symptom Cluster
The University of Hong Kong
Not applicable
80
Shenzhen
2026-03-09
Recruiting
Is Professional Tooth Cleaning Necessary for Managing Gingivitis (Gingival Inflammation) if Subjects Use Intelligent Toothbrushes?
NCT07549347Gingivitis, Periodontitis
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
92
Shanghai
2026-03-09
Recruiting
The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer
NCT07468708Healthy Adult, Prostate Cancer
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase EARLY_PHASE1
10
Guangzhou
2026-03-09
Recruiting
NK521 in the Treatment of Malignant Ascites Associated With Advanced Solid Tumors
NCT07561437Advanced Solid Tumors
Base Therapeutics (Shanghai) Co., Ltd.
Phase EARLY_PHASE1
18
Beijing
2026-03-09
Recruiting
Ferumoxytol-enhanced Magnetic Resonance Venography in Patients With Venous Diseases
NCT07452250Venous Diseases
Min Zhou
Phase 2
50
Nanjing
2026-03-08
Not yet open
Chaigui Longmu Ejiao Paste for Ischemic Heart Disease
NCT07478328Ischemic Heart Disease
Longhua Hospital
Phase 2
60
Shanghai
2026-03-08
Recruiting
Effectiveness of tTIs for Improving Consciousness in Patients With DoC
NCT07539740Disorders of Consciousness, Vegetative State, Minimally Conscious State
Zhujiang Hospital
Not applicable
136
Guangzhou
2026-03-08
Recruiting
Multi-Omics Insights Into Androgenetic Alopecia
NCT07603544Androgenetic Alopecia (AGA)
The First Affiliated Hospital of Xinxiang Medical College
Observational
12
Xinxiang
2026-03-08
Active, closed
Research of the Application of Pancreatic Cancer Screening Artificial Intelligence Model "PANDAPro"
NCT06643715Pancreatic Cancer
Zhejiang University
Not applicable
100,000
Hangzhou
2026-03-07
Recruiting
A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy Subjects
NCT07594847Healthy Adult Subject
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
72
Zibo
2026-03-07
Not yet open
Evaluation of the Outcome of Fecal Microbiota Transplantation
NCT07454408Hepatic Encephalopathy, Fecal Microbiota Transplantation, TIPS
Air Force Military Medical University, China
Phase 1/2
40
Xi’an
2026-03-07
Recruiting
Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region
NCT07370207Hepatitis B, Chronic
AusperBio Therapeutics Inc.
Phase 2
84
Hong Kong
2026-03-06
Recruiting
Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL
NCT07494565Diffuse Large B-Cell Lymphoma (DLBCL), CD5 Positive
Sun Yat-sen University
Phase 2
60
Guangzhou
2026-03-06
Recruiting
Phase II Study of RC1416 Injection in COPD
NCT07402551Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Nanjing RegeneCore Biotech Co., Ltd.
Phase 2
180
Hefei, Suzhou, Chongqing, Xiamen, Guangzhou, Huizhou, Jiangmen, Qingyuan
2026-03-06
Not yet open
A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD)
NCT07450001Pediatric Growth Hormone Deficiency
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1/2
128
Wuhan
2026-03-06
Recruiting
A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumor Patients
NCT07404202Pan-tumor(NSCLC, GYN Cancers, BTC and UC)
AstraZeneca
Observational
2,100
Beijing, Changsha, Chengdu, Guangzhou, Haerbin, Jinan, Nantong, Shanghai
2026-03-06
Not yet open
A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS)
NCT07450053Idiopathic Short Stature
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1/2
128
Wuhan
2026-03-06
Recruiting
A Phase III Study of KN026 in Combination With HB1801 as Adjuvant Therapy for Resectable HER2-Positive Breast Cancer
NCT07441460Resectable HER2-positive Breast Cancer
Shanghai JMT-Bio Inc.
Phase 3
1,800
Shanghai
2026-03-06
Recruiting
Long-term Effectiveness of the Live Attenuated Herpes Zoster Vaccine
NCT07585370Herpes Zoster
Jiangsu Province Centers for Disease Control and Prevention
Observational
24,740
Nanjing
2026-03-06
Recruiting
Efficacy and Safety of Intrapulmonary Percussive Ventilation in Patients With Pulmonary Infection Receiving Invasive Mechanical Ventilation
NCT07453966Pneumonia
Zhongnan Hospital
Not applicable
110
Wuhan
2026-03-06
Recruiting
Phase I Study of HSK42360-Na in Solid Tumors With BRAF V600 Mutation
NCT07561554Solid Tumors (Phase 1)
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
159
Beijing
2026-03-06
Recruiting
CompaRison of FEmorofemoral Bypass and Left-Heart ByPass Techniques in Open Thoracoabdominal AortIc Aneurysm Repair
NCT07518251Thoracoabdominal Aortic Aneurysm, Cardiopulmonary Bypass, Open Repair
Beijing Anzhen Hospital
Not applicable
236
Beijing
2026-03-06
Active, closed
A Real-World Exploratory Study on the Sleep-Improving Efficacy of Dong'e Brand Ejiao Yuanjiang
NCT07677709Sleeping Efficacy, Sleep Quality
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
66
Wenzhou
2026-03-06
Recruiting
CAS for Stenosis With High-risk Features for CEA
NCT07370246Carotid Artery Stenosis, Carotid Artery Stenting
Beijing Tiantan Hospital
Not applicable
212
Beijing, Chongqing, Nanning, Guiyang, Shijiazhuang, Xingtai, Wuhan, Hohhot
2026-03-06
Active, closed
Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study
NCT07534371Neuroendocrine Tumors
West China Hospital
Observational
500
Chengdu
2026-03-06
Recruiting
Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma
NCT07479732Osteosarcoma, Osteosarcoma Metastatic
Peking University People's Hospital
Phase 1/2
56
Beijing
2026-03-05
Recruiting
ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy
NCT07453407Aortic Regurgitation, Aortic Valve Insufficiency, Aortic Insufficiency
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
1,250
Hefei, Beijing, Fuzhou, Guangzhou, Zhengzhou, Hong Kong, Wuhan, Changsha
2026-03-05
Not yet open
Safety and Efficacy Evaluation of an Extensively Hydrolyzed Formula in Infants With Cow's Milk Protein Allergy (CMPA)
NCT07484035Cow's Milk Protein Allergy (CMPA)
Heilongjiang Feihe Dairy Co. Ltd.
Not applicable
124
Beijing, Foshan, Zhuhai, Xiangtan, Wuxi, Chengdu
2026-03-05
Recruiting
A Phase I Clinical Trial to Evaluate CMS-D017 Following Single and Multiple Doses in Healthy Participants
NCT07462780Paroxysmal Nocturnal Hemoglobinuria, PNH, Complement-mediated Kidney Disease
Shenzhen Kangzhe Biotechnology Co., Ltd.
Phase 1
88
Beijing
2026-03-05
Not yet open
A Study to Evaluate SHR-1139 Injection in Patients With Pyoderma Gangrenosum
NCT07444684Pyoderma Gangrenosum
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 2
20
Jinan
2026-03-05
Recruiting
A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome
NCT07319832Short Bowel Syndrome (SBS)
Takeda
Observational
12
Guangzhou, Shanghai, Hangzhou
2026-03-05
Not yet open
EUS-guided Embolization of the Visceral Artery Aneurysm
NCT07490678Aneurysm
Qilu Hospital of Shandong University
Not applicable
30
Jinan
2026-03-05
By invitation
Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors.
NCT07644403Epithelial Cancer Patients
Suzhou Immunofoco Biotechnology Co., Ltd
Phase 1/2
30
Beijing
2026-03-05
Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
NCT07438496Lupus Erythematosus, Systemic
Janssen Research & Development, LLC
Phase 3
600
Beijing, Changsha, Cheng Du Shi, Dongguan, Guangzhou, Hangzhou, Hefei, Jinhua
2026-03-05
Not yet open
Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of Gastric/Esophagogastric Junction
NCT07406984Adenocarcinoma of Gastric, Adenocarcinoma of Esophagogastric Junction
Beijing Immunochina Medical Science & Technology Co., Ltd.
Phase 1
18
Beijing
2026-03-05
Not yet open
Safety and Efficacy of Small Extracellular Vesicles Nebulizer in Patients With Allergic Rhinitis Complicated With Asthma
NCT07453771Allergic Rhinitis, Asthma
The Affiliated Hospital of Qingdao University
Not applicable
18
Guangzhou, Qingdao, Tai’an, Chongqing
2026-03-05
Recruiting
A Phase 1 Clinical Study Comparing GS101 and Dupixent® After Subcutaneous Injection
NCT07411755Atopic Dermatitis (AD)
Jiangsu Genscend Biopharmaceutical Co., Ltd
Phase 1
294
Suzhou
2026-03-05
Recruiting
Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC
NCT07459296Nasopharyngeal Carcinoma (NPC)
First Affiliated Hospital of Guangxi Medical University
Phase 3
266
Nanning
2026-03-05
Recruiting
SKB105 for Injection in Advanced Solid Tumors
NCT07380386Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1/2
256
Beijing, Shanghai
2026-03-05
Recruiting
FMD and Neoadjuvant Chemo-immunotherapy in TNBC
NCT07378306Breast Cancer
Sun Yat-sen University
Phase 2
80
Guangzhou
2026-03-05
Recruiting
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
NCT07284849CRC (Colorectal Cancer)
Incyte Corporation
Phase 3
700
Beijing, Changsha, Chengdu, Chongqing, Foshan, Fuzhou, Guangzhou, Hangzhou
2026-03-05
Recruiting
A Study of TPD3310 in Patients With Advanced Malignant Tumors
NCT07368127Advanced Malignant Solid Tumors
TAIBIDI PHARMACEUTICAL TECHNOLOGY(SHIJIAZHUANG) CO.,LTD.
Phase 1
112
Beijing
2026-03-05
Recruiting
A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutinib Tablet
NCT07374224Clinical Pharmacology
Guangzhou Lupeng Pharmaceutical Company LTD.
Phase 1
28
Beijing
2026-03-05
Recruiting
Evaluation of an EpCAM-Targeted Radiotracer in Epithelial Tumors
NCT07400263Epithelial Tumors, Malignant
Peking University People's Hospital
Not applicable
30
Beijing
2026-03-04
Active, closed
A Food-Effect Study of CX11 in Healthy Participants
NCT07349381Obesity & Overweight, Type 2 Diabetes
Vincentage Pharma Co., Ltd
Phase 1
32
Shanghai
2026-03-04
Active, closed
Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy
NCT07471815Breast Cancer Triple Negative Breast Cancer
Harbin Medical University
Phase 2
30
Harbin
2026-03-04
Not yet open
Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine
NCT07416110Rabies (Healthy Volunteers)
Sinovac Biotech Co., Ltd
Phase 3
912
Deyang, Neijiang
2026-03-04
Recruiting
A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer
NCT07349069Breast Cancer
Shandong Suncadia Medicine Co., Ltd.
Phase 3
5,500
Nanjing, Shanghai
2026-03-04
Recruiting
HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor
NCT07396584Solid Tumors, Adult
Hutchmed
Phase 1/2
186
Changchun, Changsha, Jinan, Nanning, Shanghai, Wuhan, Xiamen, Zhengzhou
2026-03-04
By invitation
A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell)
NCT07500207Rabies Prevention
Changchun BCHT Biotechnology Co.
Phase 3
3,000
Neijiang
2026-03-04
Recruiting
Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis
NCT07412249Carotid Stenosis
General Hospital of Shenyang Military Region
Not applicable
300
Shenyang
2026-03-04
By invitation
The Impact of Physical Exercise on Working Memory in Elderly People With Mild Cognitive Impairment
NCT07644156Mild Cognitive Impairment
Shanghai University of Sport
Not applicable
80
Shanghai
2026-03-04
Recruiting
Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma
NCT07445048Head & Neck Squamous Cell Carcinoma, Head & Neck Cancer, Postoperative Adjuvant Treatment
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 3
370
Shanghai
2026-03-04
Recruiting
Prediction Model for Postoperative Cognitive Dysfunction in Elderly Cardiac Patients: A Special Disease Cohort Study
NCT07483047Postoperative Cognitive Dysfunction (POCD), Cardiac Diseases Requiring Surgery
Shanghai Geriatric Medical Center
Observational
634
Shanghai
2026-03-03
Recruiting
A Study of Ziresovir (AK0529) in High-risk Adult With Respiratory Syncytial Virus (RSV) Infection.
NCT07658534Respiratory Syncytial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd.
Phase 2/3
290
Beijing, Guangzhou, Cangzhou, Nanyang, Zhengzhou, Wuhan, Hangzhou, Rui’an
2026-03-03
Not yet open
A Clinical Study Evaluating the Efficacy and Safety of CMS-D001 Tablets in the Treatment of Adult Patients With Moderate to Severe Plaque-type Psoriasis
NCT07432854Moderate to Severe Plaque Psoriasis
Dermavon Holdings Limited
Phase 2/3
540
Bengbu, Wuhu, Guangzhou, Chengde, Handan, Shijiazhuang, Harbin, Nanyang
2026-03-03
Recruiting
A Cohort Study of Combined Cryoablation and Thermal Ablation for Non-surgical Treatment of Breast Cancer Patients
NCT07238894Ablation, Breast Cancer
Peking University People's Hospital
Not applicable
200
Beijing
2026-03-03
Recruiting
A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients With Relapsed/Refractory Multiple Myeloma.
NCT07429721Multiple Myeloma (MM)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
24
Wuhan
2026-03-03
Recruiting
A Study of Bupivacaine Liposome Injection in the Treatment of Pain After Thoracoscopic Surgery
NCT06529432Local Analgesia Via Nerve Block
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
96
Shanghai
2026-03-03
Recruiting
A Study of DXC014 in Patients With Advanced Solid Tumors.
NCT07177937Small Cell Lung Cancer, Melanoma, Prostate Cancer, Other Advanced Solid Tumors
Hangzhou DAC Biotechnology Co., Ltd.
Phase 1
150
Beijing, Changsha, Nanchang, Qingdao, Hangzhou
2026-03-03
Recruiting
Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer
NCT07436741Pancreatic Cancer, Adult
Tianjin Medical University Cancer Institute and Hospital
Phase 3
106
Tianjin
2026-03-03
Recruiting
A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
NCT07227025Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC
Phase 1/2
60
Guangzhou, Harbin, Shanghai
2026-03-03
Recruiting
This Study is an Open-lable, Early Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory Small Cell Lung Cancer.
NCT07249879Relapsed/Refractory Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1
55
Beijing
2026-03-03
Recruiting
Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients With Moderate-to-Severe Atopic Dermatitis
NCT07370909Moderate to Severe Atopic Dermatitis
Shanghai Longwood Biopharmaceuticals Co., Ltd.
Phase 3
480
Beijing
2026-03-03
Recruiting
A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer
NCT07474142Newly Diagnosed, Treatment-naïve Prostate Cancer
Xijing Hospital
Observational
1,000
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2026-03-03
Recruiting
The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery
NCT07432711Video-assisted Thoracoscopic Surgery (VATS), Pain Management, Liposomal Bupivacaine, Local Injection
Beijing Tiantan Hospital
Not applicable
100
Beijing
2026-03-02
Recruiting
Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma
NCT07502287Relapsed Neuroblastoma, Refractory Neuroblastoma, High-Risk Neuroblastoma, Ganglioneuroblastoma
Beijing Biotech
Phase 1/2
36
Shenzhen
2026-03-02
Recruiting
CHOICE:Decision Factor of EGFR-TKI in Chinese IV NSCLC
NCT07413757Non-Small Cell Lung Cancer
AstraZeneca
Observational
590
Chengdu
2026-03-02
Recruiting
Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC
NCT07528066Neoadjuvant Chemoimmunotherapy, Robotic Pulmonary Resection, Stage IIB-III NSCLC
Shanghai Chest Hospital
Observational
200
Fuzhou, Guangzhou, Shenzhen, Nanjing, Qingdao, Tianjing, Shanghai
2026-03-02
Recruiting
Edaravone and Dexborneol Sublingual Tablet for Treating Chemotherapy- Induced Cognitive Impairment Study
NCT07454473Chemo Brain
Chuansheng Zhao
Phase 4
80
Shenyang
2026-03-02
Not yet open
Effects of Enteral Feeding Regimens on NEC, Mortality, and Neurodevelopment in Very Preterm Infants
NCT07045844Very Preterm Infant, Necrotizing Enterocolitis (NEC)
The Children's Hospital of Zhejiang University School of Medicine
Not applicable
2,324
Guilin, Nanning, Yulin, Guizhou, Nanyang, Zhengzhou, Yiyang, Ganzhou
2026-03-02
Recruiting
Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock
NCT07383103Septic Shock
Northern Jiangsu People's Hospital
Phase 4
336
Yangzhou
2026-03-02
Recruiting
Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer
NCT07641036Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma, Gallbladder Carcinoma
Beijing Biotech
Phase 1/2
30
Shenzhen
2026-03-02
Recruiting
Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors
NCT07523529Advanced Unresectable, Metastatic
Beijing Biotech
Phase 1/2
72
Shenzhen
2026-03-02
Recruiting
Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma
NCT07627698Unresectable Melanoma, Metastatic Cutaneous Melanoma, Metastatic Uveal Melanoma
Beijing Biotech
Phase 1/2
36
Shenzhen
2026-03-02
Recruiting
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
NCT07374848Solid Tumors, Sarcomas
Zai Lab (Shanghai) Co., Ltd.
Phase 1
180
Beijing, Shanghai
2026-03-02
Recruiting
A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 )
NCT07417189Solid Tumors, Adult
Abbisko Therapeutics Co, Ltd
Phase 1/2
401
Shanghai
2026-03-02
Recruiting
A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma
NCT07436949Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Bambusa Therapeutics
Phase 1/2
64
Beijing, Guangzhou, Changsha, Nanjing, Jinan, Qingdao, Yantai, Zibo
2026-03-02
Recruiting
SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus
NCT07523542REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS, Lupus Nephritis
Beijing Biotech
Phase 1/2
24
Shenzhen
2026-03-02
Recruiting
A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy
NCT07434050OSA - Obstructive Sleep Apnea, Obesity
Hangzhou Sciwind Biosciences Co., Ltd.
Phase 3
140
Shanghai
2026-03-02
Recruiting
Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC
NCT07500220Advanced Hepatocellular Carcinoma (HCC), Metastatic Liver Cancer
Beijing Biotech
Phase 1/2
30
Shenzhen
2026-03-02
Recruiting
Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC
NCT07641023Non-Small Cell Lung Cancer, Advanced/Metastatic
Beijing Biotech
Phase 1/2
60
Shenzhen
2026-03-02
Recruiting
Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma
NCT07627711Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable Locally Advanced, Metastatic Disease
Beijing Biotech
Phase 1/2
42
Shenzhen
2026-03-02
Recruiting
Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
NCT07510815Malignant Pleural Mesotheliomas
Beijing Biotech
Phase 1/2
36
Shenzhen
2026-03-02
Recruiting
Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma
NCT07492628Bladder Cancer, Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma
Beijing Biotech
Phase 1
42
Shenzhen
2026-03-02
Not yet open
A Study of AK112 in Combination With VG2025 in Colorectal Cancer With Liver Metastases
NCT07357220Colorectal Cancer With Hepatic Metastases
Akeso
Phase 1/2
72
Hangzhou
2026-03-02
Active, closed
Phase 2 Study of MWN109 Tablet for Weight-Loss Maintenance in Participants With Overweight or Obesity
NCT07804797Overweight , Obesity
Shanghai Minwei Biotechnology Co., Ltd
Phase 2
71
Luoyang
2026-03-02
Rows per page Showing 3401–3500 of 19052
Previous 33 34 35 36 37 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=35

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.